Melanoma News Round-Up, July 12

Hello everyone! We’re back to bring you the news highlights for all things melanoma and MRA.

JCrew 1

In celebration of UV Safety Month this July, J.Crew will donate $1 to MRA for every Instagram upload showing how you cover up and have fun in the sun.  Just tag it #JCrewSmartSun and help win donations for MRA.  Thanks to the generosity of our founders, 100% of funds raised will go directly toward melanoma research.  Stay sunsafe and help fund cutting-edge research – it’s a win-win!

This week marked game-changing progress for melanoma treatment as regulators in Japan granted the world’s 1st approval of the anti-PD-1 drug, nivolumab.  News also broke that Bristol-Myers Squibb will be seeking FDA approval of nivolumab, making this breakthrough immunotherapy available in the United States months ahead of schedule.

MRA also hailed the launch of an Expanded Access Program for advanced melanoma patients to receive a combination therapy of ipilimumab and nivolumab.  This method of combination therapy has shown promising results for late-stage melanoma patients.

On the prevention front, MRA is delighted to report Hawaii became the 10th state to ban indoor tanning for minors under 18 years of age.  There is much more work to be done to reduce everyone’s risk for skin cancer and melanoma, but the passage of this bill is a step in the right direction.

You don’t want to miss this great interview on the dangers of sun exposure and skin cancer with dermatologist, Dr. Mitchell Kline, by legendary PIX11 broadcaster, Marvin Scott.

GENlogoCMYK_092313Finally, we’re proud to share that MRA was ranked the #1 Grant-Giving Disease Foundation by Genetic Engineering & Biotechnology News (GEN).  As always, we are dedicated to finding a cure for melanoma and working toward a day when no one will suffer or die from this disease.

 

Advertisements